# SDMA Kidney Test for Cats and Dogs: Early Stage CKD Detection Guide ## Key Takeaways - Symmetric dimethylarginine (SDMA) is a methylated amino acid cleared by the kidneys, and its blood concentration rises when glomerular filtration rate (GFR) declines by approximately 25-40%, offering earlier detection of kidney dysfunction than creatinine, which typically elevates when GFR drops by 75%. - Elevated SDMA can indicate Chronic Kidney Disease (CKD), Acute Kidney Injury (AKI), dehydration, congenital kidney disease, or systemic diseases affecting kidney perfusion, necessitating a comprehensive diagnostic workup including urinalysis, blood pressure measurement, and urine protein-to-creatinine ratio (UPC). - Risk factors for CKD include advanced age, specific breeds predisposed to kidney disease, dental disease allowing bacteremia, and exposure to environmental toxins; annual wellness exams including SDMA testing are crucial for early detection. - Management of early stage CKD focuses on dietary modification (low phosphorus, moderate protein, low sodium), blood pressure control, proteinuria management with ACE inhibitors, and ensuring adequate hydration, all aimed at slowing disease progression. - The International Renal Interest Society (IRIS) has incorporated SDMA into its staging guidelines, allowing for earlier classification of CKD and more targeted therapeutic interventions, improving prognostic outlook. - Owners should monitor for subtle signs of early CKD such as increased thirst and urination, decreased appetite, lethargy, and intermittent gastrointestinal upset, and contact a veterinarian immediately for acute signs like vomiting, collapse, or no urine production. --- Chronic kidney disease (CKD) is one of the most common conditions diagnosed in older cats and dogs. For decades, veterinarians relied on serum creatinine as the primary blood marker for kidney function. The problem is that creatinine often does not rise above the normal range until approximately 75% of kidney function has already been lost. This delay makes early intervention difficult. Symmetric dimethylarginine (SDMA) is a newer kidney biomarker that changes the timeline of detection. SDMA concentrations increase earlier than creatinine as the glomerular filtration rate (GFR) declines [1][2]. This means the SDMA kidney test for cats and dogs can identify early stage CKD months or even years before traditional tests would flag a problem. This guide explains what SDMA is, how it compares to older tests, what the results mean, and how veterinarians use it to stage and manage kidney disease. **Owner Triage Summary:** If your veterinarian recommends an SDMA test, it is a routine blood test that provides a more sensitive measure of kidney function than creatinine alone. An SDMA level above 14 µg/dL in a [dog](/knowledge/veterinary-medicine/clinical-methods/dog) or [cat](/knowledge/veterinary-medicine/clinical-methods/cat) with normal urine output often indicates early kidney dysfunction. This is not an emergency, but it warrants a full diagnostic workup including urinalysis, blood pressure measurement, and urine protein testing. Early detection allows dietary changes and supportive care that can slow disease progression. If your pet is showing vomiting, lethargy, reduced appetite, or producing no urine, contact a veterinarian immediately. ## At a Glance: SDMA vs. Traditional Kidney Tests | Test | What It Measures | When It Changes | Key Limitation | |---|---------|---------|--------| | **SDMA** | A methylated amino acid cleared by the kidneys | Increases when GFR drops by roughly 25-40% | Requires validated laboratory assay | | **Creatinine** | Muscle breakdown product cleared by the kidneys | Increases when GFR drops by roughly 75% | Affected by muscle mass; can be normal in cachectic pets | | **BUN (Blood Urea Nitrogen)** | Nitrogen waste product from protein metabolism | Increases late in disease | Affected by diet, hydration, and liver function | | **Urinalysis (Specific Gravity)** | Kidney's ability to concentrate urine | Decreases early, but is non-specific | Can be affected by many non-renal diseases | ## What is SDMA and Why Does It Matter? SDMA is a byproduct of protein methylation, a normal cellular process. When proteins are turned over, methylated arginine residues are released into the bloodstream as SDMA. The kidneys clear SDMA from the blood through glomerular filtration. Because SDMA is cleared almost exclusively by the kidneys, its concentration in the blood reflects the glomerular filtration rate [1]. When kidney function declines, SDMA accumulates in the blood. This accumulation happens earlier than creatinine accumulation because SDMA has a higher clearance rate and is not influenced by muscle mass [2]. A study comparing the IDEXX SDMA Test to a reference method (liquid chromatography/mass spectrometry, or LC-MS) found that the IDEXX test had a slope of 1.06 and an intercept of 0.34 with an R² of 0.99, indicating excellent agreement with the gold standard [1]. The clinical significance is substantial. In a study of dogs and cats with CKD, SDMA increased above the reference range before creatinine did in the majority of cases [2]. This allows veterinarians to diagnose kidney disease at an earlier stage, when interventions such as dietary modification and blood pressure management are more likely to slow progression. ## Anatomy and Physiology: How the Kidneys Filter Blood The kidneys are paired organs located in the abdomen. Their functional unit is the nephron, which consists of a glomerulus (a tuft of capillaries) and a tubule. Blood enters the glomerulus, and a portion of the plasma is filtered into the tubule. This filtrate contains water, electrolytes, and waste products. As it travels through the tubule, essential substances are reabsorbed and waste products are excreted in urine. Glomerular filtration rate is the amount of plasma filtered per unit of time. It is the best overall measure of kidney function. When nephrons are lost due to disease, the remaining nephrons can compensate by increasing their filtration rate. This compensation is why creatinine levels remain normal until a large percentage of nephrons are lost. SDMA offers a different perspective. Because it is cleared by the kidneys but not secreted or reabsorbed to a significant degree, its blood concentration is directly proportional to GFR. When GFR drops, SDMA rises. This relationship holds true even when creatinine is still within the normal range [1][2]. ## Causes and Differentials of Elevated SDMA An elevated SDMA level indicates reduced glomerular filtration, but it does not specify the cause. The differential diagnosis includes: - **Chronic Kidney Disease (CKD):** The most common cause of persistently elevated SDMA in older pets. CKD is progressive and irreversible. - **Acute Kidney Injury (AKI):** A sudden drop in kidney function due to toxins (e.g., lilies in cats, antifreeze), infections, or reduced blood flow. SDMA rises faster than creatinine in AKI [1]. - **Dehydration:** Reduced blood volume lowers GFR, which can transiently raise SDMA. - **Congenital Kidney Disease:** Young animals with developmental abnormalities may have elevated SDMA. - **Systemic Diseases:** Conditions that affect kidney perfusion, such as heart failure, can reduce GFR and raise SDMA [3]. It is important to distinguish between acute and chronic disease because management differs significantly. A veterinarian will use history, physical examination, and additional tests to make this distinction. ## Risk Factors for Chronic Kidney Disease Certain factors increase the risk of CKD in cats and dogs: - **Age:** CKD is primarily a disease of older animals. The prevalence increases significantly after 7 years of age in dogs and 10 years of age in cats. - **Breed:** Some breeds are predisposed to specific kidney diseases, such as Persian cats with polycystic kidney disease and Bull Terriers with hereditary nephritis. - **Dental Disease:** Periodontal disease allows bacteria to enter the bloodstream, which can seed the kidneys and cause chronic inflammation. - **Diet:** While diet does not cause CKD, high-phosphorus diets may accelerate progression once disease is present. - **Environmental Toxins:** Exposure to lilies (cats), grapes/raisins (dogs), and certain medications can cause acute kidney injury that progresses to CKD. ## Veterinary Examination and Diagnostics When a veterinarian suspects kidney disease, the diagnostic workup includes several steps: 1. **Complete Blood Count (CBC):** To check for anemia, which can occur with CKD due to reduced erythropoietin production. 2. **Biochemistry Panel:** Includes SDMA, creatinine, BUN, phosphorus, calcium, and electrolytes. SDMA is now included in many routine wellness panels [2]. 3. **Urinalysis:** To assess urine specific gravity (concentration), check for protein, and look for casts or cells. A urine specific gravity below 1.030 in a dehydrated animal suggests kidney dysfunction. 4. **[Urine Protein-to-Creatinine Ratio](/knowledge/diagnostics/clinical-chemistry/urine-protein-to-creatinine-ratio-interpretation-in-renal-disease) (UPC):** To quantify protein loss. Proteinuria is a negative prognostic indicator. 5. **Blood Pressure Measurement:** Hypertension is common in CKD and can cause further kidney damage. 6. **Imaging:** Abdominal ultrasound or radiographs to assess kidney size, shape, and structure. The International Renal Interest Society (IRIS) has provisionally incorporated SDMA into its staging guidelines for CKD [2]. Staging is based on creatinine levels, with substaging based on SDMA, proteinuria, and blood pressure. This allows for more targeted treatment recommendations. ## Evidence-Based Management of Early Stage CKD Once CKD is diagnosed, management focuses on slowing progression and managing clinical signs. The following strategies are supported by veterinary consensus: - **Dietary Modification:** A renal diet is low in protein, phosphorus, and sodium, and supplemented with omega-3 fatty acids. This reduces the workload on the kidneys and slows the progression of disease. - **Phosphate Binders:** If dietary phosphorus restriction is insufficient, phosphate binders can be added to reduce phosphorus absorption from the gut. - **Blood Pressure Management:** Antihypertensive medications, such as amlodipine, are used to control hypertension. - **Proteinuria Management:** Angiotensin-converting enzyme (ACE) inhibitors, such as benazepril, are used to reduce protein loss in the urine. - **Hydration:** Ensuring adequate water intake is essential. Some pets benefit from subcutaneous fluid administration. - **Monitoring:** Regular rechecks with SDMA, creatinine, and blood pressure are necessary to adjust treatment. Early detection with SDMA allows these interventions to begin before significant kidney damage has occurred [2]. ## Unsafe Home Remedies and What to Avoid There are many unproven and potentially harmful "kidney detox" products marketed to pet owners. These should be avoided: - **Over-the-counter "kidney support" supplements:** Many have no evidence of efficacy and may contain ingredients that are harmful. - **Human medications:** Never give a pet human medication without veterinary approval. NSAIDs (e.g., ibuprofen) are nephrotoxic. - **High-protein diets:** While protein restriction is part of CKD management, it must be done under veterinary guidance. Severe restriction can cause muscle loss. - **Unsupervised fluid therapy:** Giving fluids at home without veterinary instruction can lead to fluid overload. ## Prevention and Prognosis CKD cannot always be prevented, but the risk can be reduced: - **Annual wellness exams:** Routine bloodwork, including SDMA, can detect kidney disease early [2]. - **Dental care:** Regular dental cleanings reduce the risk of bacteremia and kidney seeding. - **Toxin avoidance:** Keep lilies, grapes, raisins, and antifreeze out of reach. - **Fresh water:** Ensure pets always have access to clean, fresh water. The prognosis for CKD varies depending on the stage at diagnosis and the response to treatment. With early detection and management, many pets live comfortably for years. The goal is to maintain quality of life, not to cure the disease. ## Limitations and When to Contact a Veterinarian The SDMA test is a powerful tool, but it has limitations. It measures kidney function at a single point in time and does not identify the underlying cause of kidney disease. Breed-level information cannot predict an individual pet's risk or response to treatment. A single elevated SDMA level does not confirm CKD; it must be interpreted in the context of other tests and the pet's clinical condition. **Contact a veterinarian immediately if your pet shows:** - Vomiting or diarrhea (or diarrhoea) - Loss of appetite - Lethargy or weakness - Increased thirst and urination - No urine production - Seizures or collapse These signs can indicate acute kidney injury or advanced CKD, both of which require urgent veterinary care. ## Why SDMA Detects Kidney Decline Earlier Than Creatinine To understand why the SDMA kidney test for cats and dogs represents a genuine advance rather than just another lab value, it helps to look at the biology of how each molecule behaves in the body. Creatinine is a breakdown product of creatine phosphate, a compound used for muscle energy. Its production is directly proportional to muscle mass, which means a muscular dog will naturally have a higher baseline creatinine than a lean dog of the same age. More importantly, creatinine is not only filtered by the glomerulus but also actively secreted by the renal tubules to a small degree. As kidney function declines, this tubular secretion increases, partially masking the loss of filtration. The net effect is that creatinine remains in the normal range until a very large proportion of nephrons have been lost, often cited as 75% or more. SDMA behaves differently. It is produced at a relatively constant rate from the methylation of proteins throughout the body, and it is cleared almost exclusively by glomerular filtration without significant tubular secretion or reabsorption. This means its blood concentration tracks GFR more directly. When GFR drops by roughly 25% to 40%, SDMA rises above the reference range, while creatinine may still be well within normal limits [1][2]. This is not a subtle difference; it can translate into months or even years of earlier detection, depending on the rate of disease progression. Another key distinction is the influence of muscle mass. In older pets, especially cats with chronic disease, muscle wasting is common. A cat that has lost significant lean body mass will produce less creatinine, so a creatinine value in the normal range may falsely reassure the veterinarian that kidney function is adequate. SDMA is not affected by muscle mass in the same way, so it provides a more accurate reflection of true filtration capacity in cachectic or sarcopenic patients [2]. This is particularly important for senior pets, who are exactly the population most at risk for CKD. There is also a practical advantage in terms of laboratory consistency. Creatinine assays can vary between laboratories and even between runs, and values can be influenced by the patient's hydration status, recent exercise, and certain medications. SDMA has demonstrated strong agreement with the gold standard method of liquid chromatography-mass spectrometry, with studies reporting an R² of 0.99, meaning the test is highly reproducible and reliable [1]. For the owner, this means that a borderline SDMA result is less likely to be a laboratory artifact and more likely to represent a genuine change in kidney function. ## The Diagnostic Workflow: What Happens After an Elevated SDMA An elevated SDMA result is not a diagnosis; it is a signal that warrants a structured investigation. Understanding the sequence of steps your veterinarian will take can help you feel prepared and informed during the visit. The first step is to confirm the elevation with a repeat test, especially if the initial result is only mildly above the reference range. SDMA can be transiently elevated in cases of dehydration, so a veterinarian may recommend rechecking after ensuring the pet is well hydrated. If the elevation persists, the next step is a complete urinalysis. This is arguably the most important companion test to SDMA. The urine specific gravity tells the veterinarian whether the kidneys are still able to concentrate urine. In a healthy pet, urine specific gravity is typically above 1.030 in dogs and 1.035 in cats. A low specific gravity in the face of elevated SDMA strongly supports a diagnosis of kidney dysfunction, because it indicates that the tubules are no longer responding to antidiuretic hormone and reabsorbing water effectively. The urinalysis also screens for protein, glucose, blood, and cellular casts. Protein in the urine is a particularly important finding because it indicates damage to the glomerular filtration barrier. If protein is detected on a dipstick, the veterinarian will usually recommend a urine protein-to-creatinine ratio (UPC) to quantify the loss. A UPC above 0.5 in dogs or 0.4 in cats is considered proteinuric and is associated with a worse prognosis and faster disease progression. Blood pressure measurement is another essential component of the workup. Hypertension is both a consequence of CKD and a cause of further kidney damage. The kidneys play a central role in blood pressure regulation through the renin-angiotensin-aldosterone system, and when they are diseased, this system becomes dysregulated. High blood pressure can damage the glomeruli further, creating a vicious cycle. Measuring blood pressure in a veterinary clinic requires the pet to be calm and still, and multiple readings are often taken to account for "white coat" anxiety. If hypertension is confirmed, treatment with amlodipine or an ACE inhibitor is typically initiated. Imaging, usually abdominal ultrasound, provides structural information. The veterinarian can assess kidney size, shape, and echogenicity. In CKD, kidneys are often small and irregular, with increased echogenicity due to fibrosis. In acute kidney injury, kidneys may be normal or enlarged. Ultrasound can also detect kidney stones, cysts, or masses that might be contributing to the problem. In some cases, a biopsy may be recommended, though this is less common and typically reserved for cases where the underlying cause is unclear or where a specific diagnosis would change the treatment plan. ## Interpreting SDMA in the Context of IRIS Staging The International Renal Interest Society (IRIS) has developed a staging system for CKD that helps veterinarians standardize diagnosis and treatment. Traditionally, staging was based on fasting blood creatinine levels, with substaging based on proteinuria and blood pressure. The incorporation of SDMA into this framework has refined the system, allowing for earlier identification of disease and more nuanced treatment recommendations [2]. In the IRIS system, a dog or cat with a creatinine level in the normal range but an SDMA level persistently above 14 µg/dL is now considered to have Stage 1 CKD, provided other evidence of kidney disease is present, such as abnormal urinalysis findings or imaging changes. This is a significant shift because previously, these pets would have been classified as "at risk" rather than having confirmed disease. The practical implication is that these pets now qualify for early intervention, including dietary modification and closer monitoring, which can slow the progression of disease. For pets with elevated creatinine, SDMA provides additional prognostic information. A pet with creatinine in the IRIS Stage 2 range but an SDMA that is disproportionately elevated may have more severe disease than the creatinine alone suggests. Conversely, a pet with elevated creatinine but normal SDMA may have a component of dehydration or muscle mass-related creatinine elevation, and the true GFR may be better than the creatinine indicates. This distinction matters because it influences how aggressively the veterinarian will pursue treatment and how frequently monitoring should occur. It is important to note that IRIS staging is a guideline, not a rigid rule. The veterinarian will interpret the stage in the context of the individual pet's clinical signs, age, breed, and overall health. For example, a young dog with congenital kidney disease may be staged differently than an older cat with age-related decline, even if their laboratory values are similar. The staging system is a tool to facilitate communication and treatment planning, not a substitute for clinical judgment. ## Owner Observation: Recognizing the Subtle Signs of Early CKD While the SDMA test can detect kidney disease before clinical signs appear, owners are often the first to notice subtle changes that prompt a veterinary visit. These signs are easy to dismiss as normal aging, but they deserve attention, especially in senior pets. Increased thirst and urination are the classic early signs of CKD. The kidneys lose their ability to concentrate urine, so the pet produces more dilute urine and must drink more water to compensate. An owner might notice that the water bowl needs refilling more frequently, or that the cat is spending more time at the water fountain. In cats, increased urination may manifest as larger clumps in the litter box, or as inappropriate urination outside the box, which is sometimes mistaken for a behavioral issue. In dogs, there may be more frequent requests to go outside, or accidents in the house. A decrease in appetite is another common early sign. This can be subtle, such as a dog that leaves a few kibbles in the bowl or a cat that shows less enthusiasm for meals. Over time, this can lead to weight loss, which may be gradual and easy to miss. Owners may attribute this to "old age" or pickiness, but it is worth investigating, especially if it persists for more than a few days. Lethargy and decreased activity are also reported by many owners of pets with early CKD. The pet may sleep more, show less interest in play, or tire more easily on walks. This is partly due to the buildup of waste products in the blood and partly due to anemia, which develops as the kidneys produce less erythropoietin. A pet with anemia may have pale gums and a reduced tolerance for exercise. Gastrointestinal signs, such as intermittent vomiting or soft stools, can also occur in early CKD. The buildup of urea and other toxins can cause nausea and a condition called uremic gastritis. Some pets develop a distinctive breath odor that is sometimes described as "uremic" or "ammonia-like." This is not always present in early disease, but it is a sign that should not be ignored. If you notice any of these signs, it is worth scheduling a veterinary visit even if your pet seems otherwise fine. Mention the specific changes you have observed, including when they started and how often they occur. This information helps the veterinarian prioritize the diagnostic workup and interpret the laboratory results in context. ## Preparing for the Veterinary Visit: What to Bring and What to Ask A veterinary visit for suspected kidney disease can feel overwhelming, especially if the diagnosis is new. Being prepared can help you get the most out of the appointment and ensure that you leave with a clear understanding of your pet's condition and the recommended next steps. Before the visit, gather any relevant information. This includes a list of all medications and supplements your pet is currently taking, including over-the-counter products and prescription drugs. Note the dosages and how long your pet has been on each one. If your pet has had any previous bloodwork or urinalysis, bring those results or have them sent to the clinic. A history of any recent illnesses, injuries, or exposures to toxins (such as lilies, grapes, or antifreeze) is also important. Try to collect a fresh urine sample at home if possible. This can be done by placing a clean, shallow container under your dog while it urinates, or by using non-absorbent litter in a clean litter box for a cat. The sample should be collected in the morning and brought to the clinic within a few hours, kept cool in the refrigerator if there is a delay. A fresh sample is more accurate than one that has been sitting at room temperature, and it allows the veterinarian to assess urine concentration and sediment more reliably. During the visit, do not hesitate to ask questions. Useful questions include: What stage of kidney disease is my pet in, and what does that mean for their prognosis? What are the treatment options, and what are the risks and benefits of each? How often should my pet be rechecked, and what tests will be performed at those visits? Are there any dietary changes I should make, and are there specific foods you recommend? What signs should I watch for that would indicate my pet is getting worse and needs immediate attention? It is also reasonable to ask about the cost of ongoing monitoring and treatment. CKD is a chronic condition that requires lifelong management, and understanding the financial commitment can help you plan. Some clinics offer wellness plans or chronic disease management packages that can make the costs more predictable. ## The Role of Diet in Early Stage CKD Management Dietary modification is the cornerstone of CKD management, and early detection with SDMA makes it possible to start dietary intervention at a stage where it can have the greatest impact. The goals of a renal diet are to reduce the workload on the kidneys, minimize the accumulation of waste products, and slow the progression of structural damage. The most important dietary change is phosphorus restriction. High blood phosphorus levels are directly toxic to the kidneys and accelerate the progression of CKD. In early disease, the kidneys can still excrete phosphorus, but as GFR declines, phosphorus begins to accumulate. A renal diet is formulated to be low in phosphorus, and if dietary restriction alone is insufficient, phosphate binders can be added. These medications bind phosphorus in the gut, preventing its absorption into the bloodstream. Protein restriction is another key component, but it must be balanced carefully. Protein is essential for maintaining muscle mass and overall health, and excessive restriction can lead to malnutrition and sarcopenia. Renal diets are formulated to provide high-quality, highly digestible protein in moderate amounts, sufficient to meet the pet's needs without producing excessive nitrogenous waste. The goal is to reduce the production of urea and other protein breakdown products, which contribute to the clinical signs of uremia. Sodium restriction is also important, particularly in pets with hypertension. High sodium intake can raise blood pressure and increase the workload on the kidneys. Renal diets are low in sodium, which helps manage blood pressure and reduce fluid retention. Omega-3 fatty acids, particularly EPA and DHA, have anti-inflammatory properties and may help reduce the inflammation and fibrosis that characterize progressive CKD. Many renal diets are supplemented with these fatty acids, and they can also be added as a separate supplement under veterinary guidance. It is important to transition to a renal diet gradually, over a period of 7 to 10 days, to avoid gastrointestinal upset. Some pets are picky eaters and may refuse a new food, especially cats. If your cat refuses a renal diet, do not force it. Instead, discuss alternatives with your veterinarian, such as different flavors or textures, or a combination of renal and non-renal foods. The goal is to get the pet to eat an appropriate diet, and some intake of a renal diet is better than none. ## Monitoring and Adjusting Treatment Over Time CKD is a progressive disease, but the rate of progression varies widely between individuals. Regular monitoring is essential to track the disease, adjust treatment, and catch complications early. The frequency of monitoring depends on the stage of disease and the stability of the pet's condition. For pets with early stage CKD (IRIS Stage 1 or early Stage 2), monitoring every 3 to 6 months is typically recommended. Each recheck should include a biochemistry panel with SDMA and creatinine, a urinalysis, and blood pressure measurement. The SDMA level is particularly useful for tracking progression because it changes more sensitively than creatinine [2]. A rising SDMA trend, even if the value remains within the normal range, may indicate that the disease is advancing and that treatment needs to be intensified. For pets with more advanced disease, monitoring may be needed every 1 to 3 months, or even more frequently if the pet is unstable. In addition to the standard tests, the veterinarian may recommend checking blood phosphorus, calcium, and parathyroid hormone levels, as these can become abnormal as the disease progresses. Anemia is also monitored with a complete blood count, and iron supplementation or erythropoietin therapy may be considered if anemia becomes significant. Blood pressure should be checked at every recheck, as hypertension can develop or worsen over time. If a pet is on antihypertensive medication, the dose may need to be adjusted based on the blood pressure readings. Similarly, if a pet is on an ACE inhibitor for proteinuria, the UPC should be rechecked periodically to assess the response to treatment. Owner observations are also a critical part of monitoring. Keep a log of your pet's appetite, water intake, urination frequency, and energy level. Note any changes, even subtle ones, and report them to your veterinarian. Weight loss is a particularly important indicator, so weigh your pet regularly at home or at the clinic. A consistent downward trend in weight may indicate that the diet is not providing enough calories, or that the disease is progressing. ## Special Populations: Cats, Senior Pets, and Breed Considerations Cats present unique challenges in CKD diagnosis and management. Feline CKD is extremely common, affecting an estimated 30% to 50% of cats over 15 years of age. Cats are also masters at hiding illness, so clinical signs may not be apparent until the disease is advanced. The SDMA test is especially valuable in cats because they often have significant muscle wasting, which can make creatinine levels misleadingly low. A cat with a normal creatinine but elevated SDMA may have substantial kidney dysfunction that would have been missed without the SDMA test [2]. Cats also have specific dietary needs that must be considered when managing CKD. They are obligate carnivores and require adequate protein in their diet to maintain muscle mass. A renal diet for cats is formulated to be low in phosphorus but contains sufficient high-quality protein to prevent sarcopenia. Cats can be particularly resistant to dietary changes, so transitioning to a renal diet may require patience and creativity. Warming the food, offering different textures, and using appetite stimulants if needed can help. Senior pets, both cats and dogs, are the primary population affected by CKD, but they also have other age-related conditions that can complicate diagnosis and management. Arthritis, dental disease, heart disease, and cognitive decline are common in older pets, and these conditions can interact with CKD. For example, a dog with arthritis may be less active, which can affect muscle mass and creatinine levels. A cat with dental disease may have reduced appetite, which can complicate dietary management. The veterinarian will take a holistic approach, considering all of the pet's health issues when developing a treatment plan. Breed considerations are also important. Some breeds are predisposed to specific kidney diseases, such as Persian and Exotic Shorthair cats with polycystic kidney disease, and Bull Terriers with hereditary nephritis. In these breeds, SDMA testing may be recommended at a younger age, even before clinical signs appear, to establish a baseline and monitor for early changes. Other breeds, such as Golden Retrievers and Bernese Mountain Dogs, have a higher incidence of glomerular disease, which may present with proteinuria before a significant drop in GFR. In these cases, the UPC is a critical test, and SDMA may be used in conjunction to monitor progression. ## The Limitations of SDMA: What the Test Cannot Tell You While SDMA is a powerful tool, it is not a perfect test, and understanding its limitations is important for interpreting results correctly. SDMA measures the current filtration capacity of the kidneys, but it does not distinguish between acute and chronic disease. A single elevated SDMA level could indicate a sudden injury, such as exposure to a toxin, or a long-standing progressive disease. The distinction is made based on history, clinical signs, and other laboratory findings. SDMA also does not identify the underlying cause of kidney disease. A pet with elevated SDMA could have glomerulonephritis, interstitial nephritis, amyloidosis, or any number of other conditions. Determining the cause may require additional tests, including imaging, urine culture, or biopsy. In many cases, the specific cause is never identified, and the disease is simply classified as "chronic kidney disease of unknown cause," which is the most common diagnosis in older pets. There are also situations where SDMA may be elevated without true kidney disease. Dehydration is the most common cause of a transient elevation, as reduced blood volume lowers GFR. Certain medications, such as NSAIDs, can also cause a temporary reduction in GFR and a corresponding rise in SDMA. In these cases, the SDMA should return to normal once the underlying issue is resolved. This is why a single elevated SDMA result should not be used to make a diagnosis of CKD; it must be confirmed with a repeat test and a full diagnostic workup. Finally, SDMA is a measure of function, not structure. A pet can have significant structural damage to the kidneys, such as fibrosis or cysts, while maintaining a relatively normal SDMA, because the remaining healthy nephrons compensate by increasing their filtration rate. This is why SDMA is best used in combination with other tests, including urinalysis and imaging, to get a complete picture of kidney health. ## Prognosis and Quality of Life: What to Expect Long-Term The prognosis for a pet with CKD depends on several factors, including the stage at diagnosis, the presence of proteinuria and hypertension, the response to treatment, and the underlying cause of the disease. Pets diagnosed in the early stages, thanks to SDMA testing, generally have a better prognosis because interventions can be started before significant damage has occurred [2]. For pets with IRIS Stage 1 or early Stage 2 CKD, the prognosis is often good, and many pets live for years with a good quality of life. The goal of treatment is to slow the progression of disease and manage clinical signs, not to cure the disease. With appropriate dietary management, blood pressure control, and regular monitoring, many pets remain stable for extended periods. For pets with more advanced disease, the prognosis is more guarded. The median survival time for dogs with IRIS Stage 3 CKD is approximately 1 to 2 years, and for Stage 4, it is less than 6 months. Cats tend to have longer survival times than dogs at similar stages. However, these are population-level statistics, and individual outcomes vary widely. Some pets defy the odds and live much longer than expected, while others decline more rapidly. Quality of life is the most important consideration in managing CKD. The goal is to keep the pet comfortable, maintain a good appetite, and preserve the bond between pet and owner. Signs that quality of life is declining include persistent nausea or vomiting, significant weight loss, lethargy, and a lack of interest in activities the pet once enjoyed. If these signs become severe and cannot be managed with treatment, it may be time to discuss end-of-life options with your veterinarian. This is a deeply personal decision, and there is no right or wrong answer. The most important thing is to make the decision based on what is best for your pet, with the guidance of your veterinary team. ## The Future of Kidney Diagnostics: Beyond SDMA The introduction of SDMA has been a major advance in veterinary nephrology, but research continues to identify new biomarkers that may provide even earlier detection and more precise prognostic information. One area of active investigation is the use of urinary biomarkers, such as podocin and nephrin, which are proteins that are shed into the urine when glomerular podocytes are damaged. A study in dogs with degenerative mitral valve disease, a condition that can lead to cardiorenal syndrome, found that the urine podocin-to-creatinine ratio was a useful biomarker for detecting early kidney damage [3]. This suggests that urinary biomarkers may complement SDMA in the future, providing information about the specific type and location of kidney injury. Another area of research is the use of SDMA in other species. Studies have evaluated SDMA in horses with acute kidney injury and in Hermann's tortoises, suggesting that the biomarker has broad applicability across species [4][5]. While these studies are not directly relevant to cats and dogs, they demonstrate the versatility of SDMA as a measure of GFR and support its use as a general marker of kidney function. Advances in imaging, such as contrast-enhanced ultrasound and MRI, may also improve the ability to assess kidney structure and function non-invasively. These techniques are not yet widely available in general practice, but they hold promise for the future. Genetic testing is another emerging area, particularly for breeds with known hereditary kidney diseases. Identifying at-risk animals early, before clinical signs appear, could allow for earlier intervention and better outcomes. For now, SDMA remains the most sensitive and practical biomarker for early detection of CKD in cats and dogs. It is a routine blood test that is included in many wellness panels, making it accessible and affordable for most pet owners. The key is to use it as part of a comprehensive approach to kidney health, combining laboratory testing with clinical examination, owner observation, and appropriate management. ## Building a Long-Term Partnership with Your Veterinary Team Managing CKD is a marathon, not a sprint. It requires ongoing communication and collaboration between you and your veterinary team. The relationship you build with your veterinarian is one of the most important factors in achieving a good outcome for your pet. Do not hesitate to reach out to your veterinary clinic with questions or concerns between scheduled rechecks. Most clinics have staff who can answer questions over the phone or via email, and many offer telemedicine consultations for minor issues. If you notice a change in your pet's condition, such as a decrease in appetite or an increase in vomiting, contact the clinic promptly. Early intervention can often prevent a minor issue from becoming a major one. Keep a record of your pet's test results, medications, and dietary changes. This information is valuable for tracking trends over time and for communicating with any new veterinarians if you move or need to see a different provider. Many clinics now offer online portals where you can access your pet's medical records, including laboratory results. Finally, be an advocate for your pet. You know your pet better than anyone, and your observations are valuable to the veterinary team. If you feel that something is not right, say so. If a treatment is not working or is causing side effects, ask about alternatives. The best outcomes are achieved when owners and veterinarians work together as a team, with the pet's well-being as the shared goal. ## Frequently Asked Questions **1. What is the SDMA kidney test for cats and dogs?** The SDMA test measures symmetric dimethylarginine in the blood, a biomarker that reflects the glomerular filtration rate and detects kidney disease earlier than creatinine [1][2]. **2. How is the SDMA test different from a creatinine test?** SDMA increases earlier than creatinine as kidney function declines, and it is not affected by lean body mass, making it more accurate in pets with muscle loss [2]. **3. What is a normal SDMA level in dogs and cats?** The normal reference range for SDMA is typically below 14 µg/dL, though this can vary slightly by laboratory [1]. **4. Can the SDMA test be done at home?** No, the SDMA test requires a blood sample and analysis at a veterinary laboratory. It is not an at-home diagnostic test. **5. How often should SDMA be tested?** For healthy adult pets, annual testing is recommended as part of a wellness exam. For pets with CKD or other risk factors, more frequent testing may be recommended by a veterinarian. **6. Is an elevated SDMA level always a sign of kidney disease?** No, elevated SDMA can be caused by dehydration, acute kidney injury, or other conditions that reduce kidney blood flow. It requires veterinary interpretation [1]. **7. Can diet affect SDMA levels?** Unlike creatinine, SDMA is not significantly affected by diet or muscle mass, making it a more reliable indicator of kidney function [2]. **8. What should I do if my pet's SDMA is elevated?** Schedule a full veterinary workup, including urinalysis, blood pressure measurement, and possibly imaging, to determine the cause and stage of kidney disease. ## Sources [1] [Comparative performance of IDEXX SDMA Test and the DLD SDMA ELISA for the measurement of SDMA in canine and feline serum.](https://pubmed.ncbi.nlm.nih.gov/30321185/) [2] [Symmetric Dimethylarginine: Improving the Diagnosis and Staging of Chronic Kidney Disease in Small Animals.](https://pubmed.ncbi.nlm.nih.gov/27499007/) [3] [The urine podocin/creatinine ratio as a novel biomarker of cardiorenal syndrome in dogs due to degenerative mitral valve disease.](https://pubmed.ncbi.nlm.nih.gov/31356184/) [4] [Serum symmetric dimethylarginine concentration in healthy horses and horses with acute kidney injury.](https://pubmed.ncbi.nlm.nih.gov/33081772/) [5] [Symmetrical Dimethylarginine as a Diagnostic Parameter in Hermann's Tortoises (Testudo hermanni).](https://pubmed.ncbi.nlm.nih.gov/35274022/)
## Related Clinical & Scientific Guides * [Thyroid Testing in Cats: Diagnosing Hyperthyroidism and T4 Fluctuations](/knowledge/veterinary-medicine/at-home-diagnostics/thyroid-testing-in-cats-diagnosing-hyperthyroidism-and-t4-fluctuations) * [Joint Fluid Analysis in Dogs: Diagnosing Septic Arthritis vs Immune-Mediated](/knowledge/veterinary-medicine/at-home-diagnostics/joint-fluid-analysis-in-dogs-diagnosing-septic-arthritis-vs-immune-mediated) * [Blood Glucose Curves for Diabetic Pets: In-Clinic vs At-Home Monitoring](/knowledge/veterinary-medicine/at-home-diagnostics/blood-glucose-curves-for-diabetic-pets-in-clinic-vs-at-home-monitoring)